Literature DB >> 26753176

Developmental Insights into Breast Cancer Intratumoral Heterogeneity.

Mei Zhang1, Jeffrey M Rosen2.   

Abstract

Breast cancer is no longer considered a single disease, but instead is made up of multiple subtypes with genetically and most likely epigenetically heterogeneous tumors composed of numerous clones. Both the hierarchical cancer stem cell and clonal evolution models have been invoked to help explain this intratumoral heterogeneity. Several recent studies have helped define the functional interactions among the different cellular subpopulations necessary for the evolution of this complex ecosystem. These interactions involve paracrine interactions that include locally acting Wnt family members, reminiscent of the signaling pathways important for normal mammary gland development and stem cell self-renewal. In this review, we discuss the interactions among various cell populations in both normal and tumor tissues. A better understanding of these interactions, especially in the metastatic setting, will be important for the development of improved combinatorial therapies designed to prevent relapse and to ultimately decrease mortality.

Entities:  

Year:  2015        PMID: 26753176      PMCID: PMC4704125          DOI: 10.1016/j.trecan.2015.10.005

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  92 in total

Review 1.  On hormone action in the mammary gland.

Authors:  J M Rosen
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

Review 2.  Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis.

Authors:  Jane E Visvader
Journal:  Genes Dev       Date:  2009-11-15       Impact factor: 11.361

Review 3.  Cancer as an evolutionary and ecological process.

Authors:  Lauren M F Merlo; John W Pepper; Brian J Reid; Carlo C Maley
Journal:  Nat Rev Cancer       Date:  2006-11-16       Impact factor: 60.716

Review 4.  The mammary stem cell hierarchy: a looking glass into heterogeneous breast cancer landscapes.

Authors:  Amulya Sreekumar; Kevin Roarty; Jeffrey M Rosen
Journal:  Endocr Relat Cancer       Date:  2015-07-23       Impact factor: 5.678

5.  Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution.

Authors:  Peter Eirew; Adi Steif; Jaswinder Khattra; Gavin Ha; Damian Yap; Hossein Farahani; Karen Gelmon; Stephen Chia; Colin Mar; Adrian Wan; Emma Laks; Justina Biele; Karey Shumansky; Jamie Rosner; Andrew McPherson; Cydney Nielsen; Andrew J L Roth; Calvin Lefebvre; Ali Bashashati; Camila de Souza; Celia Siu; Radhouane Aniba; Jazmine Brimhall; Arusha Oloumi; Tomo Osako; Alejandra Bruna; Jose L Sandoval; Teresa Algara; Wendy Greenwood; Kaston Leung; Hongwei Cheng; Hui Xue; Yuzhuo Wang; Dong Lin; Andrew J Mungall; Richard Moore; Yongjun Zhao; Julie Lorette; Long Nguyen; David Huntsman; Connie J Eaves; Carl Hansen; Marco A Marra; Carlos Caldas; Sohrab P Shah; Samuel Aparicio
Journal:  Nature       Date:  2014-11-26       Impact factor: 49.962

6.  Selective targeting of radiation-resistant tumor-initiating cells.

Authors:  Mei Zhang; Rachel L Atkinson; Jeffrey M Rosen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-03       Impact factor: 11.205

7.  Fibroblast growth factor receptor signaling is essential for normal mammary gland development and stem cell function.

Authors:  Adam C Pond; Xue Bin; Torey Batts; Kevin Roarty; Susan Hilsenbeck; Jeffrey M Rosen
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

8.  Chemotherapy and cancer stem cells.

Authors:  Jeremy N Rich; Shideng Bao
Journal:  Cell Stem Cell       Date:  2007-10-11       Impact factor: 24.633

9.  Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo.

Authors:  Arnaud André Mailleux; Bradley Spencer-Dene; Christian Dillon; Delphine Ndiaye; Catherine Savona-Baron; Nobuyuki Itoh; Shigeaki Kato; Clive Dickson; Jean Paul Thiery; Saverio Bellusci
Journal:  Development       Date:  2002-01       Impact factor: 6.868

10.  Mammary stem cells have myoepithelial cell properties.

Authors:  Michael D Prater; Valérie Petit; I Alasdair Russell; Rajshekhar R Giraddi; Mona Shehata; Suraj Menon; Reiner Schulte; Ivo Kalajzic; Nicola Rath; Michael F Olson; Daniel Metzger; Marisa M Faraldo; Marie-Ange Deugnier; Marina A Glukhova; John Stingl
Journal:  Nat Cell Biol       Date:  2014-08-31       Impact factor: 28.824

View more
  9 in total

1.  Proapoptotic PUMA targets stem-like breast cancer cells to suppress metastasis.

Authors:  Qi Sun; Jacqueline Lesperance; Hiromi Wettersten; Elaine Luterstein; Yoko S DeRose; Alana Welm; David A Cheresh; Jay S Desgrosellier
Journal:  J Clin Invest       Date:  2017-12-11       Impact factor: 14.808

Review 2.  Advancements in Cancer Stem Cell Isolation and Characterization.

Authors:  Heena Jariyal; Chanchal Gupta; Vedika Sandeep Bhat; Jayant Ramakant Wagh; Akshay Srivastava
Journal:  Stem Cell Rev Rep       Date:  2019-12       Impact factor: 5.739

3.  Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.

Authors:  Hanna Taipaleenmäki; Nicholas H Farina; Andre J van Wijnen; Janet L Stein; Eric Hesse; Gary S Stein; Jane B Lian
Journal:  Oncotarget       Date:  2016-11-29

4.  PIK3CA mutations are common in lobular carcinoma in situ, but are not a biomarker of progression.

Authors:  Vandna Shah; Salpie Nowinski; Dina Levi; Irek Shinomiya; Narda Kebaier Ep Chaabouni; Cheryl Gillett; Anita Grigoriadis; Trevor A Graham; Rebecca Roylance; Michael A Simpson; Sarah E Pinder; Elinor J Sawyer
Journal:  Breast Cancer Res       Date:  2017-01-17       Impact factor: 6.466

5.  Limited utility of tissue micro-arrays in detecting intra-tumoral heterogeneity in stem cell characteristics and tumor progression markers in breast cancer.

Authors:  Pascale Kündig; Charlotte Giesen; Hartland Jackson; Bernd Bodenmiller; Bärbel Papassotirolopus; Sandra Nicole Freiberger; Catharine Aquino; Lennart Opitz; Zsuzsanna Varga
Journal:  J Transl Med       Date:  2018-05-08       Impact factor: 5.531

6.  Re-evaluating the role of epithelial-mesenchymal-transition in cancer progression.

Authors:  Andrew Sulaiman; Ze-Min Yao; Li-Sheng Wang
Journal:  J Biomed Res       Date:  2018-03-26

Review 7.  Wnt signaling in breast cancer: biological mechanisms, challenges and opportunities.

Authors:  Xiufang Xu; Miaofeng Zhang; Faying Xu; Shaojie Jiang
Journal:  Mol Cancer       Date:  2020-11-24       Impact factor: 27.401

8.  CircRNA circYY1 (hsa_circ_0101187) Modulates Cell Glycolysis and Malignancy Through Regulating YY1 Expression by Sponging miR-769-3p in Breast Cancer.

Authors:  Xiaobin Zhang; Jiehua Li; Qin Feng
Journal:  Cancer Manag Res       Date:  2021-02-09       Impact factor: 3.989

9.  PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells.

Authors:  Kie Honjo; Taiji Hamada; Takuya Yoshimura; Seiya Yokoyama; Sohsuke Yamada; Yan-Qin Tan; Lai K Leung; Norifumi Nakamura; Yasuyo Ohi; Michiyo Higashi; Akihide Tanimoto
Journal:  Oncotarget       Date:  2018-07-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.